Tumors of the salivary gland in Mexicans. A retrospective study of 360 cases

被引:30
作者
Mejia-Velazquez, Claudia-Patricia [1 ]
Duran-Padilla, Marco-Antonio [2 ]
Gomez-Apo, Erick
Quezada-Rivera, Daniel [3 ]
Gaitan-Cepeda, Luis-Alberto [4 ]
机构
[1] Univ Nacl Autonoma Mexico, Fac Odontol, Div Estudios Postgrad & Invest, Dent Sch,Lab Patol Clin & Expt, Coyoacan 04510, DF, Mexico
[2] Gen Hosp Mexico, Surg Pathol Serv, Mexico City, DF, Mexico
[3] Univ Nacl Autonoma Mexico, Grad & Res Div, Sch Dent, Histopathol Diag Serv, Coyoacan 04510, DF, Mexico
[4] Univ Nacl Autonoma Mexico, Sch Dent, Grad & Res Div, Clin & Expt Pathol Lab, Coyoacan 04510, DF, Mexico
来源
MEDICINA ORAL PATOLOGIA ORAL Y CIRUGIA BUCAL | 2012年 / 17卷 / 02期
关键词
Salivary glands tumours; epithelial tumours; pleomorphic adenoma; papillary cistadenoma lymphomatosum; adenoid cystic carcinoma; mucoepidermoid carcinoma; PAROTID-GLAND; POPULATION; NEOPLASMS; EXPERIENCE;
D O I
10.4317/medoral.17434
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Objective: To establish distribution frequency and demographic characteristics of salivary gland tumours (SGT) in order to identify possible risk profiles. Design of study: The present report constitutes an eight year retrospective study (January 2000-August 2007). The archives of the Clinical and Experimental Pathology Laboratory (Graduate and Research Division, Dental School, National Autonomous University of Mexico) as well as archives of the Surgical Pathology Service (General Hospital, Mexico City) were subject to revision in order to select all cases where SGT tumour diagnoses were emitted. Age and gender of patients as well as SGT topography were obtained from medical records. Selected cases were classified according to location of the lesion, histological lineage and biological behaviour. Results: 360 cases of SGT were included, 227 (67%) cases were benign tumours, while 83 cases (23%) were malignant tumours. SGT were most frequent in women with ages ranging from their 3rd to 5th decades of life. 275 tumours were located in major salivary glands, 78.9% of them were identified in the parotid gland. The most frequent location of tumours arising from minor salivary glands (33 cases, 38%) was found in the palatine glands. Tumours of epithelial lineage were the predominant histological type. The most frequent benign tumours were pleomorphic adenomas (86.1%) and papillary cystadenoma lymphomatosum (7.3%). The most frequent malignant tumours were adenoid cystic carcinomas (25%) and mucoepidermoid carcinomas (23.6%) Conclusions: Salivary gland tumours in Mexican population appear principally in major salivary glands of women in their 3rd to 5th decade of life.
引用
收藏
页码:E183 / E189
页数:7
相关论文
共 30 条
  • [1] Salivary tumors in north Jordanians: A descriptive study
    Al-Khateeb, Taiseer Hussain
    Ababneh, Khansa T.
    [J]. ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTOLOGY, 2007, 103 (05): : E53 - E59
  • [2] Salivary gland tumors in an Iranian population: A retrospective study of 130 cases
    Ansari, Mobammad Hussein
    [J]. JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2007, 65 (11) : 2187 - 2194
  • [3] SALIVARY-GLAND TUMORS IN ZIMBABWE - REPORT OF 282 CASES
    CHIDZONGA, MM
    PEREZ, VML
    ALVAREZ, ALP
    [J]. INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 1995, 24 (04) : 293 - 297
  • [4] Childers Esther L B, 2002, Ann Diagn Pathol, V6, P339, DOI 10.1053/adpa.2002.36662
  • [5] Mesenchymal neoplasms of the major salivary glands: clinicopathological features of 18 cases
    Cho, Kyung-Ja
    Ro, Jae Y.
    Choi, Jene
    Choi, Seung-Ho
    Nam, Soon Yuhl
    Kim, Sang Yoon
    [J]. EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2008, 265 (Suppl 1) : S47 - S56
  • [6] ENEROTH CM, 1971, CANCER, V27, P1415, DOI 10.1002/1097-0142(197106)27:6<1415::AID-CNCR2820270622>3.0.CO
  • [7] 2-X
  • [8] TUMORS OF THE MINOR (OROPHARYNGEAL) SALIVARY-GLANDS - A DEMOGRAPHIC-STUDY OF 336 CASES
    EVESON, JW
    CAWSON, RA
    [J]. JOURNAL OF ORAL PATHOLOGY & MEDICINE, 1985, 14 (06) : 500 - 509
  • [9] FOOTE FW, 1953, CANCER-AM CANCER SOC, V6, P1065, DOI 10.1002/1097-0142(195311)6:6<1065::AID-CNCR2820060602>3.0.CO
  • [10] 2-0